Timeline
American Cancer Society BrightEdge
ACS-affiliated oncology venture fund; co-invested in CellCentric's £170m Series D.
1 of 1 entries (1 events, 0 interactions)
Filters
#4 5 May
ACS-affiliated oncology venture fund; co-invested in CellCentric's £170m Series D.
1 of 1 entries (1 events, 0 interactions)